Messenger (m)RNA is increasingly investigated as a platform technology. The delivery of the genetic information offers potentially broad therapeutic applications. For almost all mRNA therapeutics the sequence is introduced by a linear DNA template. Those linear DNA templates can be manufactured via different strategies what comes with additional challenges, but also provides options to affect the behavior of the desired mRNA product.
Senior Director DNA Process Development & Cap Technology,
You must be logged in and own this session in order to